Carlos Brites
Biographic Data
| ID | 5621812 |
|---|---|
| NAME | Carlos Brites |
| GIVEN NAMES | Carlos |
| FAMILY NAME | Brites |
| SIGNATURE | BRITES C |
| AFFILIATIONS | Universidade Federal da Bahia |
| ORCID | 0000-0002-4673-6991 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2002 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Benchmarking large language models for clinical data extraction from Portuguese medical notes in a university hospital
Extracting structured data from electronic health records (EHRs) remains a major challenge, particularly in non-English and resource-constrained healthcare systems. This study benchmarks multiple large language models (LLMs) for the automated extraction of structured clinical variables from Portuguese-language medical notes under limited computational resources. We evaluated five LLMs (GPT-4o mini, DeepSeek-V3, Mixtral-8x7B, LLaMA 8B, and Qwen-32…
Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil
Background: Human T cell lymphotropic virus type 1 (HTLV-1) is highly endemic in Brazil, necessitating surveillance studies to understand its epidemiology. While previous research has focused on either specific cities or populations, there is a need for multicenter studies encompassing epidemiologically relevant populations to ascertain more accurate prevalence rates and predictors of HTLV-1 infection in the country. Methods: We conducted a multi…
Confirmatory validation of the transgender health care humanization scale
The THcH scale is a reliable and valid tool for promoting sensitivity and awareness among healthcare professionals, thereby enhancing healthcare access and quality for the transgender population. Further research should expand its application to primary care and diverse populations and settings
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine
Patient-reported outcomes (PROs) facilitate communication between patients and providers, enhancing patient-centered care. We report PROs for virologically suppressed people living with HIV-1 who switched to dolutegravir/lamivudine (DTG/3TC) or continued their 3- or 4-drug current antiretroviral regimen (CAR) in the phase 3 SALSA study. Secondary endpoints included change from baseline in HIV Treatment Satisfaction Questionnaire (status version; …
Validation of the HIV/Aids-Targeted Quality of Life (HAT-QOL) for Evaluation of Health-related Quality of Life in People Living with HIV/Aids in Brazil
Health-related quality of life
Clinical and Laboratory Outcomes in HIV-1 and HTLV-1/2 Coinfection
Low Quality of Life, Falls, and Pre-Frailty are Associated with Depressive Symptoms in Virologically Suppressed PLWHIV in Salvador, Brazil
Adherence Study
Prevalence and Risk of Blood-Borne and Sexually Transmitted Viral Infections in Incarcerated Youth in Salvador, Brazil
Reducing Aids Risk Among Men Who Have Sex with Men in Salvador, Brazil
No prominent works on this page.
Reducing Aids Risk Among Men Who Have Sex with Men in Salvador, Brazil
Adherence Study
Prevalence and Risk of Blood-Borne and Sexually Transmitted Viral Infections in Incarcerated Youth in Salvador, Brazil
Low Quality of Life, Falls, and Pre-Frailty are Associated with Depressive Symptoms in Virologically Suppressed PLWHIV in Salvador, Brazil
Clinical and Laboratory Outcomes in HIV-1 and HTLV-1/2 Coinfection
Health-related quality of life
Confirmatory validation of the transgender health care humanization scale
The THcH scale is a reliable and valid tool for promoting sensitivity and awareness among healthcare professionals, thereby enhancing healthcare access and quality for the transgender population. Further research should expand its application to primary care and diverse populations and settings
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine
Patient-reported outcomes (PROs) facilitate communication between patients and providers, enhancing patient-centered care. We report PROs for virologically suppressed people living with HIV-1 who switched to dolutegravir/lamivudine (DTG/3TC) or continued their 3- or 4-drug current antiretroviral regimen (CAR) in the phase 3 SALSA study. Secondary endpoints included change from baseline in HIV Treatment Satisfaction Questionnaire (status version; …
Validation of the HIV/Aids-Targeted Quality of Life (HAT-QOL) for Evaluation of Health-related Quality of Life in People Living with HIV/Aids in Brazil
Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil
Background: Human T cell lymphotropic virus type 1 (HTLV-1) is highly endemic in Brazil, necessitating surveillance studies to understand its epidemiology. While previous research has focused on either specific cities or populations, there is a need for multicenter studies encompassing epidemiologically relevant populations to ascertain more accurate prevalence rates and predictors of HTLV-1 infection in the country. Methods: We conducted a multi…
Benchmarking large language models for clinical data extraction from Portuguese medical notes in a university hospital
Extracting structured data from electronic health records (EHRs) remains a major challenge, particularly in non-English and resource-constrained healthcare systems. This study benchmarks multiple large language models (LLMs) for the automated extraction of structured clinical variables from Portuguese-language medical notes under limited computational resources. We evaluated five LLMs (GPT-4o mini, DeepSeek-V3, Mixtral-8x7B, LLaMA 8B, and Qwen-32…
Medicine (9 works) · HIV/AIDS Research and Interventions (6 works) · Public health (5 works) · Environmental health (4 works) · Health psychology (4 works) · Human immunodeficiency virus (HIV (4 works) · Internal Medicine (4 works) · Nursing (4 works) · Gerontology (3 works) · HIV-related health complications and treatments (3 works)